Skip to main content
Top
Published in: Systematic Reviews 1/2021

Open Access 01-12-2021 | Chronic Obstructive Lung Disease | Protocol

Prevalence, risk factors, and interventions for chronic obstructive pulmonary disease in South Asia: a scoping review protocol

Authors: Rafiqul Islam, Md. Tarek Hossain, Nantu Chakma, Afroza Khanom, Tapas Mazumder, Md. Tauhidul Islam

Published in: Systematic Reviews | Issue 1/2021

Login to get access

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is increasingly contributing to the disease burden in South Asia. This review will summarize the prevalence and risk factors of COPD in South Asia and the interventions regarding COPD that have been introduced in South Asian countries.

Method

This scoping review will primarily follow Arksey and O’Malley’s six steps of scoping review methodology. Additionally, it will follow the recent upgradation of the scoping review methodology by Levac et al., and the Joanna Briggs Institute. Research questions were already identified at the beginning of the proposed scoping review. Electronic databases will be searched (PubMed, Web of Science, and ProQuest) using search terms. Studies will be screened independently by two reviewers through a two-stage screening process using pre-developed inclusion criteria for this scoping review. Eligible studies will be abstracted and charted in a standardised form. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) will be used to report the result. Additionally, feedback from South Asia’s experienced COPD researchers on the final literature list will be collected for gap identification in literature search. Two independent reviewers will assess the quality of each included study’s design using the Joanna Briggs Institute’s tool.

Discussion

The proposed scoping review will map the evidence on COPD in South Asia through literature review, and it will focus on prevalence, risk factors, and interventions. This review will contribute to the advancement of research on COPD and will be beneficial for policy-makers, public health specialists, and clinicians.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–82.PubMedCrossRef Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–82.PubMedCrossRef
2.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.PubMedCrossRef Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.PubMedCrossRef
3.
go back to reference GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma. Lancet. 2017;5(9):691–706. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma. Lancet. 2017;5(9):691–706.
4.
go back to reference James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef
5.
go back to reference Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.CrossRef Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.CrossRef
6.
go back to reference Alwan A, World Health Organization. Global status report on non-communicable diseases 2010. Geneva: World Health Organization; 2011. Alwan A, World Health Organization. Global status report on non-communicable diseases 2010. Geneva: World Health Organization; 2011.
7.
go back to reference Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Heal Epidemiol Genomics. 2018;3:e4.CrossRef Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Heal Epidemiol Genomics. 2018;3:e4.CrossRef
8.
go back to reference Ghani E. The poor half billion in South Asia. India: Oxford University Press; 2010. Ghani E. The poor half billion in South Asia. India: Oxford University Press; 2010.
9.
go back to reference Institute of Health Metrics and Evaluation, Human Development Network, The World Bank. The Global Burden of Disease: Generating Evidence, Guiding Policy – South Asia Regional Edition. Seattle: IHME; 2013. Institute of Health Metrics and Evaluation, Human Development Network, The World Bank. The Global Burden of Disease: Generating Evidence, Guiding Policy – South Asia Regional Edition. Seattle: IHME; 2013.
11.
go back to reference Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2): 020415 (17 pages). Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2): 020415 (17 pages).
13.
go back to reference Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–80.PubMedPubMedCentralCrossRef Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–80.PubMedPubMedCentralCrossRef
14.
go back to reference Kurmi OP, Semple S, Simkhada P, Cairns S, Smith W, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65(3):221–8.PubMedCrossRef Kurmi OP, Semple S, Simkhada P, Cairns S, Smith W, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65(3):221–8.PubMedCrossRef
15.
go back to reference Borup H, Kirkeskov L, Hanskov DJA, Brauer C. Systematic review: chronic obstructive pulmonary disease and construction workers. Occup Med. 2017;67(3):199–204.CrossRef Borup H, Kirkeskov L, Hanskov DJA, Brauer C. Systematic review: chronic obstructive pulmonary disease and construction workers. Occup Med. 2017;67(3):199–204.CrossRef
16.
go back to reference Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns. 2011;83(1):29–36.PubMedCrossRef Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns. 2011;83(1):29–36.PubMedCrossRef
17.
go back to reference Bolton CE, Waters CS, Peirce S, Elwyn G. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract. 2011;17(6):1216–22.PubMedCrossRef Bolton CE, Waters CS, Peirce S, Elwyn G. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract. 2011;17(6):1216–22.PubMedCrossRef
18.
go back to reference Cruz J, Brooks D, Marques A. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract. 2014;68(3):69–78.CrossRef Cruz J, Brooks D, Marques A. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract. 2014;68(3):69–78.CrossRef
19.
go back to reference Lemmens KMM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103(5):670–91.PubMedCrossRef Lemmens KMM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103(5):670–91.PubMedCrossRef
20.
go back to reference Sutradhar I, Das Gupta R, Hasan M, Wazib A, Sarker M. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Bangladesh: A Systematic Review. Cureus. 2019;11(1): e3970 (14 pages). Sutradhar I, Das Gupta R, Hasan M, Wazib A, Sarker M. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Bangladesh: A Systematic Review. Cureus. 2019;11(1): e3970 (14 pages).
22.
go back to reference Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32.CrossRef Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32.CrossRef
24.
go back to reference The Joanna Briggs Institute. The Joanna Briggs Institute Reviewers’ Manual 2015. Adelaide; 2015. The Joanna Briggs Institute. The Joanna Briggs Institute Reviewers’ Manual 2015. Adelaide; 2015.
25.
go back to reference Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. Br Med J. 2004;328(7430):39–41.CrossRef Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. Br Med J. 2004;328(7430):39–41.CrossRef
26.
go back to reference Cohen J. A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef Cohen J. A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef
27.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed
30.
go back to reference Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef
Metadata
Title
Prevalence, risk factors, and interventions for chronic obstructive pulmonary disease in South Asia: a scoping review protocol
Authors
Rafiqul Islam
Md. Tarek Hossain
Nantu Chakma
Afroza Khanom
Tapas Mazumder
Md. Tauhidul Islam
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-020-01556-7

Other articles of this Issue 1/2021

Systematic Reviews 1/2021 Go to the issue